Treatment Guidelines from The Medical Letter
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Treatment Guidelines from The Medical Letter | |
|---|---|
| Abbreviated title | Treat Guidel Med Lett |
| Discipline | publication |
| Language | English |
| Publication details | |
| Publisher | The Medical Letter, Inc. (USA) |
| Publication history | first published 2001 |
| Indexing | |
| ISSN | 1541-2792}} |
| Links | |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Treatment Guidelines from The Medical Letter is published monthly (12 issues/year) by The Medical Letter, Inc., which also publishes The Medical Letter on Drugs and Therapeutics. The newsletter provides independent, unbiased reviews of drug classes for treatment of some common disorders. A typical issue of Treatment Guidelines contains recommendations for first choice and alternative drugs with assessments of the drugs’ effectiveness, safety and cost.
Editorial process
An expert consultant or one of the editors prepares the preliminary draft using both published and available unpublished studies that are carefully examined, paying special attention to the results of well controlled clinical trials.
The preliminary draft is edited and sent to every member of the Advisory Board, to 10-20 other investigators who have clinical experience with the drug or type of drug or disease under review, to the Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC), to the first authors of all the articles cited in the text. Copies of the original draft are also sent to the drug manufacturers who are responsible for developing these compounds.
Many critical observations, suggestions and questions are received from the reviewers and are incorporated into the article during the revision process, and the article is checked and edited to make sure the final appraisal is not only accurate, but also easy to read.
flowchart of the editorial process
External links
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
